Browsing by Author Khasraw, Mustafa

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 31  next >
Issue DateTitleAuthor(s)Citation
2016The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trialsChan, David; Clarke, Stephen; Khasraw, Mustafa; Lee, Adrian; Li, Bob; Marx, Gavin; Pavlakis, Nick; Barnes, Tristan; Drilon, Alexander D.; Kris, Mark G.; Naidoo, Jarushka; Rudin, Charles M.; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Central Clinical School: Pathology; SAHCS: Medicine; Northern Clinical School: MedicineThe addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials, Lung Cancer, vol.102, N/A, 2016,pp 21-27
2016Ageing, Chronic Disease and Injury: A Study in Western Victoria (Australia)Khasraw, Mustafa; Brumby, Susan; Dunning, Trisha; et al, Various; Hakkennes, Sharon; Holloway, Kara; Kotowicz, Mark A; Livingston, Patricia; Page, Richard; Pedler, Daryl; Sajjad, M. Amber; Sutherland, Alasdair; NH&MRC Clinical Trials CentreAgeing, Chronic Disease and Injury: A Study in Western Victoria (Australia), Journal of Public Health Research, vol.5, 2, 2016,pp 81-86
2014Antiangiogenic therapy for high-grade gliomaKhasraw, Mustafa; Pavlakis, Nick; Ameratunga, Malaka S; Grant, Robin; Wheeler, Helen T.; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: MedicineAntiangiogenic therapy for high-grade glioma, Cochrane Database of Systematic Reviews, vol.2014, 9, 2014,pp 1-42
2014Bevacizumab for the treatment of high-grade glioma: an update after phase III trialsKhasraw, Mustafa; Ameratunga, Malaka S; Grommes, Christian; School of Public Health: NH&MRC Clinical Trials CentreBevacizumab for the treatment of high-grade glioma: an update after phase III trials, Expert Opinion on Biological Therapy, vol.14, 5, 2014,pp 729-740
2014Brain metastases in breast cancerKhasraw, Mustafa; Hao-Wen, Sim; Morris, Patrick; Patil, Sujata; School of Public Health: NH&MRC Clinical Trials CentreBrain metastases in breast cancer, Expert Review of Anticancer Therapy, vol.14, 2, 2014,pp 173-183
2015CDK4/6 inhibitors in breast cancerKhasraw, Mustafa; Dukelow, Tim; Kishan, Divya; Murphy, Conleth G.; NH&MRC Clinical Trials CentreCDK4/6 inhibitors in breast cancer, Anti-Cancer Drugs, vol.26, 8, 2015,pp 797-806
2016Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trialBack, Michael; Khasraw, Mustafa; Lee, Adrian; Wheeler, Helen; Ackland, Stephen; Buyse, Marc E.; Kerestes, Z; Kichenadasse, G; McCowatt, Sally; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Northern Clinical School: MedicineCilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial, Journal of Neuro-Oncology, vol.128, 1, 2016,pp 163-171
2016Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trialBack, Michael; Khasraw, Mustafa; Lee, Adrian; Wheeler, Helen; Ackland, Stephen; Buyse, Marc E.; Kerestes, Z; Kichenadasse, G; McCowatt, Sally; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Northern Clinical School: MedicineCilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial, Journal of Neuro-Oncology, vol.128, 1, 2016,pp 163-171
2017Combination of palbociclib and radiotherapy for glioblastomaKhasraw, Mustafa; Chung, Sylvia; Day, B; Johns, Terrance; Joshi, Swapna; Madani, Daniel; McDonald, Kerrie; Whittaker, Shane; NH&MRC Clinical Trials CentreCombination of palbociclib and radiotherapy for glioblastoma, Cell Death Discovery, vol.3, N/A, 2017,pp 1-6
2017Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?Khasraw, Mustafa; Lester, A.; McDonald, Kerrie; Nixdorf, S.; Rapkins, Robert; NH&MRC Clinical Trials CentreCombining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?, Clinical and Translational Oncology, vol.19, 3, 2017,pp 273-278
2016A Discrete Choice Experiment to Examine the Preferences of Patients With Cancer and Their Willingness to Pay for Different Types of Health Care AppointmentsKhasraw, Mustafa; Ashley, David; Collins, Ian; Dunning, Trisha; Hayes, Theresa Margaret; Lorgelly, Paula Kate; Norman, Richard; Wong, Shu Fen; NH&MRC Clinical Trials CentreA Discrete Choice Experiment to Examine the Preferences of Patients With Cancer and Their Willingness to Pay for Different Types of Health Care Appointments, Journal of the National Comprehensive Cancer Network, vol.14, 3, 2016,pp 311-319
2017Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: proposal for a Novel Grading Scheme with Prognostic SignificanceBailey, Dale; Clarke, Stephen; Diakos, Connie; Engel, Alexander; Eslick, Enid; Khasraw, Mustafa; Pavlakis, Nick; Roach, Paul; Samra, Jaswinder; Schembri, Geoff; Barnes, Tristan; Bernard, Elizabeth J; Chan, David; Hayes, Aimee; Hsiao, Edward; Medical Imaging and Radiation Sciences; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Central Clinical School: Medicine; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Northern Clinical School: Imaging; Northern Clinical School: Surgery; Northern Clinical School: MedicineDual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: proposal for a Novel Grading Scheme with Prognostic Significance, Theranostics, vol.7, 5, 2017,pp 1149-1158
2015EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer ModelBean, Andrew G; Bruce, Matthew P; et al, Various; Gantier, Michael P; Khasraw, Mustafa; Wang, Li; Wang, Tao; Ward, Alister; Wei, Ming; Xiang, Dongxi; Zhou, ShuFengEpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model, Theranostics, vol.5, 12, 2015,pp 1456-1472
2014Epidermal growth factor receptor-tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung: a meta-analysisGebski, Val; Khasraw, Mustafa; Ameratunga, Malaka S; Broad, Adam; Pavlakis, Nick; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEpidermal growth factor receptor-tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung: a meta-analysis, Asia-Pacific Journal of Clinical Oncology, vol.10, 3, 2014,pp 273-278
2016Evolving management of low grade glioma: No consensus amongst treating cliniciansKhasraw, Mustafa; Sawkins, Kate; Field, K.M.; Nowak, Anna K.; Rosenthal, M.A.; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreEvolving management of low grade glioma: No consensus amongst treating clinicians, Journal of Clinical Neuroscience, vol.23, N/A, 2016,pp 81-87
2017Geographic region, socioeconomic position and the utilisation of primary total joint replacement for hip or knee osteoarthritis across western Victoria: a cross-sectional multilevel study of the Australian Orthopaedic Association National Joint Replacement RegistryKhasraw, Mustafa; Brennan-Olsen, Sharon; Dunning, Trisha; et al, Various; Hakkennes, Sharon; Holloway, Kara; Kotowicz, Mark A; Livingston, Patricia; Page, R; Sajjad, M. Amber; Vogrin, S; NH&MRC Clinical Trials CentreGeographic region, socioeconomic position and the utilisation of primary total joint replacement for hip or knee osteoarthritis across western Victoria: a cross-sectional multilevel study of the Australian Orthopaedic Association National Joint Replacement Registry, Archives of Osteoporosis, vol.12, 1, 2017,pp 1-7
2016ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumoursGebski, Val; Khasraw, Mustafa; Pavlakis, Nick; Thavaneswaran, Subotheni; Wilson, Kate; Chantrill, Lorraine A; Day, Fiona; Desai, Jayesh; Elez, Elena; et al, Various; Jefford, Michael; Nott, Louise M; Segelov, Eva; Underhill, Craig; Waring, Paul; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours, BMC Cancer, vol.16, 1, 2016,pp 1-8
2016Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignanciesKhasraw, Mustafa; de Groot, John; et al, Various; Fuller, Gregory; Garber, Sarah; Gatalica, Zoran; Hashimoto, Yuuri; Verhaak, Roel; Weathers, Shiao-Pei; Xiu, Joanne; Zhou, Shouhao; NH&MRC Clinical Trials CentreImmune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies, Neuro-Oncology, vol.18, 10, 2016,pp 1357-1366
2016Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignanciesKhasraw, Mustafa; de Groot, John; et al, Various; Fuller, Gregory; Garber, Sarah; Gatalica, Zoran; Hashimoto, Yuuri; Verhaak, Roel; Weathers, Shiao-Pei; Xiu, Joanne; Zhou, Shouhao; NH&MRC Clinical Trials CentreImmune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies, Neuro-Oncology, vol.18, 10, 2016,pp 1357-1366
2017Immune Checkpoint Inhibitors for Brain MetastasesKhasraw, Mustafa; Menzies, Alexander Maxwel; Pavlakis, Nick; Heimberger, Amy B; Tan, Aaron C; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Northern Clinical School: MedicineImmune Checkpoint Inhibitors for Brain Metastases, Current Oncology Reports, vol.19, 6, 2017,pp 1-12